Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, September 2009, p. 3989-3991, Vol. 53, No. 9
0066-4804/09/$08.00+0 doi:10.1128/AAC.00722-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Leonard Wood Memorial, Cebu, the Philippines,1 Department of Antimicrobial Research, Tibotec BVBA, Johnson & Johnson, Beerse, Belgium2
Received 28 May 2009/ Returned for modification 12 June 2009/ Accepted 5 July 2009
The diarylquinoline R207910 is profoundly bactericidal in a murine model of tuberculosis. Previously, R207910 was also found to be bactericidal for Mycobacterium leprae-infected mice during lag phase. Herein we evaluate the bactericidal efficacy of R207910 (1 to 120 mg/kg of body weight) when administered five times weekly, once weekly, and once monthly during logarithmic multiplication of M. leprae organisms. All treatments were found to be bactericidal, suggesting that both low and intermittent dosing with R207910 holds promise for leprosy patients.
Published ahead of print on 13 July 2009.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»